Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines

Abstract

BackgroundDioscin, a typical steroid saponin, is isolated from Dioscorea nipponica Makino and Dioscorea zingiberensis Wright. It has estrogenic activity and many studies have also reported that dioscorea plants have an effect in preventing and treating osteoporosis. However, the molecular mechanisms underlying their effect on osteoporosis treatment are poorly understood. Therefore, the present study aims to investigate the mechanism (s) by which dioscin promotes osteoblastic proliferation and differentiation in mouse pre-osteoblast like MC3T3-E1 cells and human osteoblast-like MG-63 cells.ResultsWe found that dioscin (0.25 μg/ml, 0.5 μg/ml, and 1.0 μg/ml) promoted MC3T3-E1 cells and MG-63 cells proliferation and differentiation dose dependently. Western blot analysis results showed that estrogen receptor α (ER-α), estrogen receptor β (ER-β), β-catenin and Bcl-2 protein expression increased after MC3T3-E1 cells were treated with dioscin. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis indicated that dioscin could increase the ratio of osteoprotegerin (OPG)/receptor activator of NF-κB ligand (RANKL) and up-regulate the level of Lrp5 and β-catenin. And by RNA interference analysis, we proved that the effect of dioscin increasing the ratio of OPG/RANKL was dependent on Lrp5 pathway. In addition, we also found that these effects of dioscin were abolished by ICI 182, 780 (100 nM), an antagonist of ER, indicating that an ER signaling pathway was also involved. We also found that dioscin (0.25 μg/ml, 0.5 μg/ml, and 1.0 μg/ml) induced MG-63 cells proliferation and differentiation in a dose-dependent manner. Western blot analysis results indicated that ER-α, ER-β and β-catenin protein expression increased after MG-63 cells were treated with dioscin.ConclusionsThe current study is the first to reveal that dioscin can promote osteoblasts proliferation and differentiation via Lrp5 and ER pathway.

Epigallocatechin-3-gallate Promotes Osteoblastic Activity in Human Osteoblast-like Cells

“…Among various osteoblast differentiation markers, ALP is known as a representative marker for the early stage of differentiation, and is a critical indicator of the initiation of mineralization during bone formation [2]. In our results, EGCG could significantly increase ALP activity and also the mineralization activity, indicating that EGCG has great potential in promoting osteoblastic activities.…”

“…Osteoporosis has drawn more and more attention from medical researchers because it is becoming an increasing risk for human health and quality of life [1]. Osteoporosis is caused by imbalance between bone formation and bone resorption, which relies on the interactions between osteoblasts and osteoclasts [2,3]. Osteoblasts, known as bone-forming cells, are the major osteoprogenitor cells, whose proliferation and differentiation will eventually result in the formation of the mineralized extracellular matrix [4].…”

Formononetin Induces Apoptosis of Human Osteosarcoma Cell Line U2OS by Regulating the Expression of Bcl-2, Bax and MiR-375 In Vitro and In Vivo

“…Kallio et al found that osteoblast apoptosis was induced by E 2 through ER-mediated through osteosarcoma U2OS cell line experiments in vitro experiments [13]. Estrogen has been shown to promote proliferation of human osteosarcoma cells, and thus anti-estrogen therapy may be an effective tool in treating osteosarcomas [14][15][16].…”

Collagen-derived dipeptide prolyl-hydroxyproline promotes differentiation of MC3T3-E1 osteoblastic cells

“…Cells were then washed twice with deionized water and 5% silver nitrate was added. Cells were exposed to ultraviolet (UV) light for 15 h. Finally, the cells were fixed with 5% sodium thiosulfate for 5 min [16]. Mineralized nodules were scanned using an image scanner and analyzed qualitatively using Image J software.…”